New antibiotic compound enters phase I clinical trial
Wednesday, November 9, 2011 - 07:30
in Health & Medicine
(Medical Xpress) -- Novacta Biosystems has commenced dosing of the first healthy volunteers in a phase I clinical trial of a new antibiotic to treat the hospital superbug Clostridium difficile.